This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification. Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus (HPV). WARREN, N.J., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,
Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose by more than 2% on the day, thanks largely to news from a rival. Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy, which competes directly with Eli Lilly's Zepbound.
Shares of Arm Holdings (NASDAQ: ARM) were trading higher this week. The company's stock gained 8.9% as of market close but was up as much as 13% earlier in the week. President Trump's new AI infrastructure initiative, Project Stargate, helped boost AI stocks across the board, but Arm's relationship with Oracle could mean it benefits more than most.
We recently published a list of 10 AI News You Should Definitely Take a Look At. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other AI news you should definitely take a look at. New AI Initiative Promises Jobs and Infrastructure Boost in the U.S. President […]
We recently published a list of 15 Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks ChatGPT predicts could make you wealthy in 10 years. 2024 was a stellar year for the US markets, driven […]
Nvidia (NASDAQ: NVDA) is the undisputed leader in the artificial intelligence (AI) chip market these days. Two of Nvidia's key rivals, Advanced Micro Devices and Intel, are hoping to chip away at its market share. While it's possible that some of its customers may want to diversify their supply chains and explore cheaper options, Nvidia's recent announcement of its new graphics cards is a sign that it isn't about to relinquish any of its market share easily.
Wall Street’s rally pauses as key indexes (^DJI, ^IXIC, ^GSPC) face pressure from weak chip stocks, uncertainty ahead of the first Federal Reserve meeting of 2025, and Big Tech earnings reports to be released next week. Eric Freedman, US Bank Asset Management chief investment officer, joins Market Domination Overtime to share his outlook on the market and on Big Tech earnings, noting that he sees Big Tech remaining strong with ongoing investment in technology. "Our viewpoint is that companies are spending money, getting bigger, stronger, faster through technology spend ... everything from data services to AI," Freedman says. "Until that cycle stops, that’s the place we want to be allocating capital." He adds, "We do expect there to be a little bit of rationing back in expectations, but still think this is a market to own until proven otherwise." To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Josh Lynch
The surge comes as the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) were up 1.7% and 1.6%, respectively. Oracle is a featured player in President Trump's new artificial intelligence (AI) infrastructure initiative, Project Stargate, and also benefited from developments regarding the TikTok ban. Select members from the AI industry, including Oracle chief Larry Ellison, were present at the White House as President Trump announced his new program.